Marshall Wace’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $25.2M | Sell |
1,414,599
-392,992
| -22% | -$7M | 0.03% | 451 |
|
|
2025
Q1 | $32.2M | Buy |
1,807,591
+1,536,639
| +567% | +$27.4M | 0.04% | 358 |
|
|
2024
Q4 | $8.07M | Sell |
270,952
-508,718
| -65% | -$15.2M | 0.01% | 805 |
|
|
2024
Q3 | $12.2M | Buy |
779,670
+282,196
| +57% | +$4.41M | 0.01% | 626 |
|
|
2024
Q2 | $8.52M | Sell |
497,474
-272,053
| -35% | -$4.66M | 0.01% | 733 |
|
|
2024
Q1 | $12M | Buy |
769,527
+422,099
| +121% | +$6.6M | 0.02% | 601 |
|
|
2023
Q4 | $5.19M | Buy |
347,428
+284,067
| +448% | +$4.24M | 0.01% | 751 |
|
|
2023
Q3 | $1.02M | Sell |
63,361
-153,241
| -71% | -$2.47M | ﹤0.01% | 1261 |
|
|
2023
Q2 | $8.99M | Buy |
216,602
+200,516
| +1,247% | +$8.32M | 0.02% | 679 |
|
|
2023
Q1 | $967K | Buy |
+16,086
| New | +$967K | ﹤0.01% | 1429 |
|
|
2022
Q3 | – | Sell |
-104,760
| Closed | -$7.28M | – | 2914 |
|
|
2022
Q2 | $7.28M | Buy |
+104,760
| New | +$7.28M | 0.02% | 1004 |
|
|
2022
Q1 | – | Sell |
-3,572
| Closed | -$268K | – | 3078 |
|
|
2021
Q4 | $268K | Buy |
+3,572
| New | +$268K | ﹤0.01% | 2394 |
|
|
2021
Q1 | – | Sell |
-2,951
| Closed | -$511K | – | 2397 |
|
|
2020
Q4 | $511K | Buy |
+2,951
| New | +$511K | ﹤0.01% | 1316 |
|
|
2018
Q2 | – | Sell |
-16,500
| Closed | -$360K | – | 801 |
|
|
2018
Q1 | $360K | Buy |
+16,500
| New | +$360K | 0.01% | 430 |
|